Accordingly, a meta-analysis study showed that higher expression of the CSC biomarker LGR5 was associated with poor prognosis in CRC patients, supporting the need for a better understanding of the biological characteristics of different colorectal tumours required to guide therapeutic decisions [15]. Here, LGR5 is linked to colorectal neoplasm.